Company page

Eyepoint, Inc.

Eyepoint, Inc. is a public company traded under the ticker EYPT in the American market, with a market capitalization of approximately $1.14 billion. The company focuses on innovative treatments for eye diseases, leveraging its proprietary drug delivery technologies. Eyepoint aims to improve patient outcomes through its advanced therapeutic solutions.